Literature DB >> 8349528

The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora.

I R Rowland1, R Tanaka.   

Abstract

The effect on various caecal bacteria and their metabolic activities of feeding diet containing transgalactosylated oligosaccharides (TOS) with or without Bifidobacterium breve (administered in the drinking water) was investigated in rats colonized with a human faecal microflora. TOS (5% w/w in diet) or TOS plus B. breve, given for 4 weeks, induced increases in caecal concentration of total anaerobic bacteria, lactobacilli and bifidobacteria, and decreases in numbers of enterobacteria. Caecal pH was significantly reduced by feeding TOS, as were the activities of beta-glucuronidase and nitrate reductase. In contrast, beta-glucosidase activity was increased in TOS-fed rats. Dietary TOS was also associated with decreased conversion, by caecal contents, of the dietary carcinogen 2-amino-3-methyl-3H-imidazo[4,5-f] quinoline (IQ) to its genotoxic 7-hydroxy derivative.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349528     DOI: 10.1111/j.1365-2672.1993.tb05201.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


  14 in total

1.  Effect of fermented soy milk on the intestinal bacterial ecosystem.

Authors:  I-Chi Cheng; Huey-Fang Shang; Tzann-Feng Lin; Tseng-Hsing Wang; Hao-Sheng Lin; Shyh-Hsiang Lin
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

2.  Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men.

Authors:  Ellen G H M van den Heuvel; Daniel Wils; Wilrike J Pasman; Marie-Hélène Saniez; Alwine F M Kardinaal
Journal:  Eur J Nutr       Date:  2005-02-09       Impact factor: 5.614

3.  Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis.

Authors:  R M Satokari; E E Vaughan; A D Akkermans; M Saarela; W M de Vos
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

4.  Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome.

Authors:  Jose M Bruno-Barcena; M Andrea Azcarate-Peril
Journal:  J Funct Foods       Date:  2015-01       Impact factor: 4.451

5.  Movement and fixation of intestinal microbiota after administration of human feces to germfree mice.

Authors:  Ryoko Kibe; Mitsuo Sakamoto; Hiroshi Yokota; Hiroki Ishikawa; Yuji Aiba; Yasuhiro Koga; Yoshimi Benno
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

6.  Optimization of enzymatic hydrolysis of copra meal: compositions and properties of the hydrolysate.

Authors:  Tipawan Thongsook; Sirilux Chaijamrus
Journal:  J Food Sci Technol       Date:  2018-07-19       Impact factor: 2.701

7.  Effects of galacto-oligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice.

Authors:  Géraldine Leforestier; Anne Blais; François Blachier; Agnès Marsset-Baglieri; Anne-Marie Davila-Gay; Emmanuel Perrin; Daniel Tomé
Journal:  Eur J Nutr       Date:  2009-07-04       Impact factor: 5.614

Review 8.  The role of gut microbiota in the pathogenesis of colorectal cancer.

Authors:  Qingchao Zhu; Renyuan Gao; Wen Wu; Huanlong Qin
Journal:  Tumour Biol       Date:  2013-02-10

Review 9.  Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: a review.

Authors:  Aleksandra Duda-Chodak; Tomasz Tarko; Paweł Satora; Paweł Sroka
Journal:  Eur J Nutr       Date:  2015-02-12       Impact factor: 5.614

10.  Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model.

Authors:  Francois-Pierre J Martin; Yulan Wang; Norbert Sprenger; Ivan K S Yap; Serge Rezzi; Ziad Ramadan; Emma Peré-Trepat; Florence Rochat; Christine Cherbut; Peter van Bladeren; Laurent B Fay; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-07-15       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.